NEW DELHI: The Union Ayush ministry said on Tuesday that it was illegal to advertise Ayurveda, Siddha, Unani, and Homeopathy drugs claiming "miraculous or supernatural effects," saying that it was detrimental to public health.
"It is illegal to advertise ASU&H drugs claiming miraculous or supernatural effects for the treatment of diseases. Such advertisements can mislead and endanger public health by promoting unverified or false claims," the ministry said.
It also advised the public to seek consultation from medical practitioners before taking these drugs.
"General public are advised to use such medications only after consultations with registered medical practitioners/doctors of concerned Ayush systems," the ministry said.
"Public is also encouraged to report any such objectionable advertisements, false claims, fake medicines etc to the concerned State Licensing Authority or the Ministry of Ayush for an appropriate action," it added.
It cautioned against self-diagnosis or self-medication using Ayurveda, Siddha, Unani, and Homeopathy (ASU&H) drugs and medicines.
The ministry also said that the Drugs and Magic Remedies (Objectionable Advertisements) Act of 1954 strictly prohibits the advertising of drugs and magic remedies for specific diseases and conditions.
Stay updated with the latest news on Times of India. Don't miss daily games like Crossword, Sudoku, and Mini Crossword.The TOI News Desk comprises a dedicated and tireless team of jour...
Read MoreThe TOI News Desk comprises a dedicated and tireless team of journalists who operate around the clock to deliver the most current and comprehensive news and updates to the readers of The Times of India worldwide. With an unwavering commitment to excellence in journalism, our team is at the forefront of gathering, verifying, and presenting breaking news, in-depth analysis, and insightful reports on a wide range of topics. The TOI News Desk is your trusted source for staying informed and connected to the ever-evolving global landscape, ensuring that our readers are equipped with the latest developments that matter most."
Read Less